Kathleen D. Scott, Chief Financial Officer at ARS Pharmaceuticals, Inc. (SPRY), sold 50,000 shares at $14.10 ($705K) on 2025-05-20, disclosed to the SEC on 2025-05-22.
Open-market sale of $705k SPRY by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SPRY | SELL | 2024-10-17 | $200K | — | Filing → |
| SPRY | SELL | 2024-08-21 | $200K | — | Filing → |
| SPRY | BUY | 2022-12-01 | $51K | — | Filing → |